Vertex Pharmaceuticals Incorporated - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Vertex Pharmaceuticals Incorporated (Vertex or "the company") involved in the discovery, development and commercialization of new medicines. The company operates R&D facilities in Boston, Providence, San Diego, and Oxford (UK). It offers products for cystic fibrosis (CF) treatment including Kalydeco (ivacaftor), Symdeko/Symkevi (tezacaftor/ivacaftor and ivacaftor), Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor and ivacaftor) and Orkambi (ivacaftor/lumacaftor). Vertex is involved in curing various disease including sickle cell disease, Thalassemia, and cystic fibrosis. It primarily operates in the US, Canada, and Europe. The company is headquartered in Boston, Massachusetts, the US.Scope
- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Vertex Pharmaceuticals Incorporated: Company Overview
- Vertex Pharmaceuticals Incorporated: Overview and Key Facts
- Vertex Pharmaceuticals Incorporated: Overview
- Vertex Pharmaceuticals Incorporated: Key Facts
- Vertex Pharmaceuticals Incorporated: Key Employees
- Vertex Pharmaceuticals Incorporated: Key Employee Biographies
- Vertex Pharmaceuticals Incorporated: Major Products and Services
- Vertex Pharmaceuticals Incorporated: Management Statement
- Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
- Vertex Pharmaceuticals Incorporated: Key Competitors
- Vertex Pharmaceuticals Incorporated: Company Analysis
- Vertex Pharmaceuticals Incorporated: Business Description
- Vertex Pharmaceuticals Incorporated: SWOT Analysis
- Vertex Pharmaceuticals Incorporated: SWOT Overview
- Vertex Pharmaceuticals Incorporated: Strengths
- Vertex Pharmaceuticals Incorporated: Weaknesses
- Vertex Pharmaceuticals Incorporated: Opportunities
- Vertex Pharmaceuticals Incorporated: Threats
- Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity
- Vertex Pharmaceuticals Incorporated: Financial Deals Overview
- Vertex Pharmaceuticals Incorporated: Targets and Partners
- Vertex Pharmaceuticals Incorporated: Top Deals 2021 - 2025YTD*
- Vertex Pharmaceuticals Incorporated: Advisors
- Vertex Pharmaceuticals Incorporated: Top Legal Advisors
- Vertex Pharmaceuticals Incorporated: Top Financial Advisors
- Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions
- Vertex Pharmaceuticals Incorporated: Corporate Venturing
- Vertex Pharmaceuticals Incorporated: Partnership
- Vertex Pharmaceuticals Incorporated: Recent Developments
- Vertex Pharmaceuticals Incorporated: News and Events Summary
- Vertex Pharmaceuticals Incorporated: Business Expansion
- Vertex Pharmaceuticals Incorporated: Financial Deals
- Vertex Pharmaceuticals Incorporated: Financial Performance
- Vertex Pharmaceuticals Incorporated: Grants
- Vertex Pharmaceuticals Incorporated: Market Developments
- Vertex Pharmaceuticals Incorporated: Research & Development
- Vertex Pharmaceuticals Incorporated: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 9: Vertex Pharmaceuticals Incorporated: Top Deals 2021 - 2025YTD*
Table 10: Vertex Pharmaceuticals Incorporated: Legal Advisor Ranking by Value (US$m)
Table 11: Vertex Pharmaceuticals Incorporated: Financial Advisor Ranking by Value (US$m)
Table 12: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2021 - YTD*2025)
Table 13: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2021 - YTD*2025)
Table 14: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 15: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2021 - YTD*2025)
Table 16: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 17: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 18: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 19: Vertex Pharmaceuticals Incorporated: Business Expansion
Table 20: Vertex Pharmaceuticals Incorporated: Financial Deals
Table 21: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 22: Vertex Pharmaceuticals Incorporated: Grants
Table 23: Vertex Pharmaceuticals Incorporated: Market Developments
Table 24: Vertex Pharmaceuticals Incorporated: Research & Development
Table 25: Vertex Pharmaceuticals Incorporated: Strategy and Operations
List of Figures
Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 5: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2021 - YTD*2025)
Figure 6: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Figure 7: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2021 - YTD*2025)
Figure 8: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 9: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2021 - YTD*2025)
